26 March 2021 5 Min Read
Hong Kong suspends BioNTech vaccines amid packaging defects
BioNTech will conduct a probe at its production facilities, while Hong Kong will examine whether the logistics process caused the defects
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In